Castle Biosciences Cash from Financing (TTM) Trends

Castle Biosciences Inc (CSTL)

19.20 +0.36 (+1.91%) USD | NASDAQ | Apr 18, 16:00

19.16 -0.04 (-0.21%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	-2.298M
September 30, 2023	0.249M
June 30, 2023	0.592M
March 31, 2023	1.027M
December 31, 2022	1.515M
September 30, 2022	2.391M
June 30, 2022	3.897M
March 31, 2022	5.127M
December 31, 2021	5.421M
September 30, 2021	233.12M
June 30, 2021	239.37M

Date	Value
March 31, 2021	306.84M
December 31, 2020	305.89M
September 30, 2020	78.29M
June 30, 2020	146.56M
March 31, 2020	78.14M
December 31, 2019	88.29M
September 30, 2019	92.48M
June 30, 2019	16.10M
March 31, 2019	21.20M
December 31, 2018	15.84M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-2.298M

Minimum

Dec 2023

306.84M

Maximum

Mar 2021

84.37M

Average

16.10M

Median

Jun 2019

Cash from Financing (TTM) Benchmarks